Ivax Confident On Flonase Generic In 2004, Despite Bioequivalence Petitions
This article was originally published in The Tan Sheet
Executive Summary
Ivax expects approval for a generic version of GlaxoSmithKline's nasal steroid Flonase (fluticasone) sometime this year
You may also be interested in...
Glaxo Defends Flonase From Generics With Manufacturing Spec Petition
GlaxoSmithKline is attempting to impede generic competition for itsFlonase nasal steroid with the filing of the second citizen petition this year related to the product
Glaxo Defends Flonase From Generics With Manufacturing Spec Petition
GlaxoSmithKline is attempting to impede generic competition for itsFlonase nasal steroid with the filing of the second citizen petition this year related to the product
Glaxo Defends Flonase From Generics With Manufacturing Spec Petition
GlaxoSmithKline is attempting to impede generic competition for itsFlonase nasal steroid with the filing of the second citizen petition this year related to the product